| Autor: |
Dik JW; a Department of Medical Microbiology, University Medical Center Groningen , University of Groningen , Groningen , The Netherlands., Hendrix R; a Department of Medical Microbiology, University Medical Center Groningen , University of Groningen , Groningen , The Netherlands.; b Medical Microbiology , Certe Laboratory for Infectious Diseases , Groningen , The Netherlands., Poelman R; a Department of Medical Microbiology, University Medical Center Groningen , University of Groningen , Groningen , The Netherlands., Niesters HG; a Department of Medical Microbiology, University Medical Center Groningen , University of Groningen , Groningen , The Netherlands., Postma MJ; c Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy , University of Groningen , Groningen , The Netherlands.; d Institute of Science in Healthy Aging & healthcaRE (SHARE), University Medical Center Groningen , University of Groningen , Groningen , The Netherlands.; e Department of Epidemiology, University Medical Center Groningen , University of Groningen , Groningen , The Netherlands., Sinha B; a Department of Medical Microbiology, University Medical Center Groningen , University of Groningen , Groningen , The Netherlands., Friedrich AW; a Department of Medical Microbiology, University Medical Center Groningen , University of Groningen , Groningen , The Netherlands. |
| Abstrakt: |
Antimicrobial Stewardship Programs (ASPs) are being implemented worldwide to optimize antimicrobial therapy, and thereby improve patient safety and quality of care. Additionally, this should counteract resistance development. It is, however, vital that correct and timely diagnostics are performed in parallel, and that an institution runs a well-organized infection prevention program. Currently, there is no clear consensus on which interventions an ASP should comprise. Indeed this depends on the institution, the region, and the patient population that is served. Different interventions will lead to different effects. Therefore, adequate evaluations, both clinically and financially, are crucial. Here, we provide a general overview of, and perspective on different intervention strategies and methods to evaluate these ASP programs, covering before mentioned topics. This should lead to a more consistent approach in evaluating these programs, making it easier to compare different interventions and studies with each other and ultimately improve infection and patient management. |
